HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stamatios Theocharis Selected Research

Peroxisome Proliferator-Activated Receptors (PPAR)

1/2024The role of peroxisome proliferator-activated receptors in endometriosis.
5/2023The Role of Peroxisome Proliferator-Activated Receptors in Endometrial Cancer.
4/2023The Role of Peroxisome Proliferator-Activated Receptors in Polycystic Ovary Syndrome.
1/2023The Role of Peroxisome Proliferator-Activated Receptors in Preeclampsia.
11/2012The role of peroxisome proliferator-activated receptor-γ in breast cancer.
10/2012Expression of peroxisome proliferator activated receptor-gamma (PPAR-γ) in human non-small cell lung carcinoma: correlation with clinicopathological parameters, proliferation and apoptosis related molecules and patients' survival.
2/2011Peroxisome proliferator-activated receptor-γ in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stamatios Theocharis Research Topics

Disease

133Neoplasms (Cancer)
04/2024 - 06/2002
30Carcinogenesis
03/2024 - 12/2008
17Neoplasm Metastasis (Metastasis)
04/2024 - 09/2007
15Inflammation (Inflammations)
03/2024 - 09/2009
11Adenocarcinoma
02/2023 - 06/2002
10Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2017 - 02/2011
9Breast Neoplasms (Breast Cancer)
12/2022 - 01/2012
9Colonic Neoplasms (Colon Cancer)
11/2019 - 06/2002
8Hepatocellular Carcinoma (Hepatoma)
04/2024 - 08/2006
8Carcinoma (Carcinomatosis)
03/2024 - 06/2002
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2019 - 06/2002
7Reperfusion Injury
05/2021 - 09/2008
6Pancreatic Neoplasms (Pancreatic Cancer)
09/2021 - 05/2009
5Disease Progression
06/2023 - 07/2011
5Endometrial Neoplasms (Endometrial Cancer)
05/2023 - 01/2013
5Lung Neoplasms (Lung Cancer)
12/2022 - 06/2002
5Pituitary Neoplasms (Pituitary Adenoma)
10/2022 - 12/2008
5Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 10/2009
4Hematologic Neoplasms (Hematological Malignancy)
03/2024 - 03/2022
4Liver Diseases (Liver Disease)
05/2023 - 05/2007
4Melanoma (Melanoma, Malignant)
03/2022 - 05/2021
4Atherosclerosis
05/2017 - 01/2011
4Carotid Artery Diseases
10/2012 - 07/2010
4Atherosclerotic Plaque (Atheroma)
12/2011 - 03/2007
3Sarcoma (Soft Tissue Sarcoma)
11/2023 - 05/2022
3Lung Injury
01/2022 - 01/2016
3Ischemia
05/2021 - 09/2008
3Uveal melanoma
05/2021 - 09/2020
3Kidney Diseases (Kidney Disease)
01/2020 - 07/2010
3Lymphatic Metastasis
01/2017 - 03/2010
3Infections
01/2014 - 03/2010
3Pain (Aches)
08/2013 - 02/2011
2Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2024 - 03/2022
2Endometriosis
01/2024 - 01/2023
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
11/2023 - 01/2021
2Obesity
09/2023 - 01/2018
2Glandular and Epithelial Neoplasms (Neoplasms, Glandular)
07/2022 - 04/2022
2Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 01/2013
2Necrosis
01/2022 - 01/2017
2Pneumonia (Pneumonitis)
01/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

48Proteins (Proteins, Gene)FDA Link
10/2023 - 06/2002
30Biomarkers (Surrogate Marker)IBA
03/2024 - 10/2009
22LigandsIBA
12/2022 - 06/2002
17EphrinsIBA
03/2024 - 08/2013
12Histone Deacetylases (Histone Deacetylase)IBA
03/2024 - 02/2013
12Histone Deacetylase InhibitorsIBA
06/2023 - 10/2011
12AntigensIBA
09/2021 - 06/2008
12PPAR gammaIBA
10/2012 - 06/2002
9Eph Family Receptors (Eph Receptors)IBA
02/2022 - 09/2011
7Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2024 - 02/2011
7EnzymesIBA
10/2023 - 09/2008
6Histones (Histone)IBA
10/2023 - 10/2011
6MicroRNAs (MicroRNA)IBA
04/2023 - 11/2016
6ParaffinIBA
10/2021 - 06/2008
5CannabinoidsIBA
02/2024 - 01/2015
5Messenger RNA (mRNA)IBA
10/2023 - 01/2015
5ErythropoietinFDA Link
08/2023 - 03/2022
5Phosphotransferases (Kinase)IBA
08/2023 - 04/2015
4Protein Isoforms (Isoforms)IBA
01/2024 - 07/2021
4tyrosine receptor (receptor, tyrosine)IBA
08/2023 - 12/2021
4Immune Checkpoint InhibitorsIBA
08/2022 - 05/2019
4Matrix Metalloproteinases (MMPs)IBA
01/2022 - 12/2008
4Pregnane X ReceptorIBA
10/2021 - 01/2013
4LipidsIBA
03/2021 - 01/2012
4Glucose (Dextrose)FDA LinkGeneric
01/2019 - 06/2002
4PaxillinIBA
09/2017 - 12/2014
4Focal Adhesion Protein-Tyrosine KinasesIBA
01/2017 - 12/2010
4EndocannabinoidsIBA
01/2016 - 04/2013
4Transcription Factors (Transcription Factor)IBA
09/2014 - 05/2009
3CytokinesIBA
01/2022 - 01/2016
3AntioxidantsIBA
05/2021 - 09/2008
3Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 01/2014
3Bile Acids and Salts (Bile Acids)IBA
01/2019 - 01/2012
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2018 - 01/2015
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2018 - 12/2011
3Retinoid X Receptors (Retinoid X Receptor)IBA
10/2015 - 05/2009
3Toll-Like Receptors (Toll-Like Receptor)IBA
08/2010 - 11/2008
2Metformin (Glucophage)FDA LinkGeneric
03/2024 - 06/2023
2Insulin (Novolin)FDA Link
03/2024 - 09/2008
2InflammasomesIBA
02/2024 - 06/2022
2Cruciform DNA (Holliday Junctions)IBA
10/2023 - 07/2022
2ChromatinIBA
10/2023 - 07/2022
2Untranslated RNA (Noncoding RNA)IBA
04/2023 - 04/2022
2Cadherins (E-Cadherin)IBA
10/2022 - 01/2017
2CreatinineIBA
08/2022 - 07/2010
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2022 - 08/2012
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022 - 08/2006
2ELAV-Like Protein 1IBA
01/2022 - 01/2021
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2016
2Phenobarbital (Luminal)FDA Link
10/2021 - 07/2018
2RNA-Binding Proteins (RNA-Binding Protein)IBA
09/2021 - 07/2018
2CarcinogensIBA
01/2021 - 06/2006
2CD40 Ligand (CD40L)IBA
10/2020 - 01/2018
2Dextran SulfateIBA
10/2020 - 06/2018
2AzoxymethaneIBA
10/2020 - 06/2018

Therapy/Procedure

36Therapeutics
03/2024 - 04/2006
13Drug Therapy (Chemotherapy)
03/2024 - 11/2004
9Immunotherapy
01/2024 - 05/2019
2Radiotherapy
03/2024 - 04/2022
2Endoscopes
09/2022 - 06/2022